| Date | Time | Source | Headline | Symbol | Company |
| 05/02/2024 | 2:07PM | iHub Newswire | FeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon | | |
| 09/14/2017 | 12:41PM | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 04/25/2017 | 5:17PM | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 11/02/2016 | 3:37PM | Edgar (US Regulatory) | Withdrawal of Registration Statement (rw) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 05/27/2016 | 6:06AM | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 05/20/2016 | 6:04AM | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 05/05/2016 | 12:18PM | Edgar (US Regulatory) | Securities Registration (section 12(b)) (8-a12b) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 04/28/2016 | 4:13PM | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 04/20/2016 | 6:05AM | Edgar (US Regulatory) | Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 04/19/2016 | 6:06AM | Edgar (US Regulatory) | Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |
| 04/19/2016 | 6:06AM | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | AMEX:CPP | Cancer Prevention Pharmaceuticals, Inc. |